Exploring how different RA treatments affect cholesterol profiles and cardiovascular risk in rheumatoid arthritis patients.
Explore how synthetic and biological DMARDs are transforming rheumatoid arthritis treatment according to the 2022 EULAR guidelines.
Comparative analysis of bDMARDs and tsDMARDs for rheumatoid arthritis treatment, including efficacy rankings and safety profiles.
Exploring the effectiveness of switching between IL-6 receptor inhibitors and JAK inhibitors in rheumatoid arthritis treatment based on real-world data from the CorEvitas registry.